These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 3387170)
1. Mixtures of low molecular weight surfactant proteins and dipalmitoyl phosphatidylcholine duplicate effects of pulmonary surfactant in vitro and in vivo. Smith GB; Taeusch HW; Phelps DS; Keough KM Pediatr Res; 1988 May; 23(5):484-90. PubMed ID: 3387170 [TBL] [Abstract][Full Text] [Related]
2. Role of bovine pulmonary surfactant-associated proteins in the surface-active property of phospholipid mixtures. Yu SH; Possmayer F Biochim Biophys Acta; 1990 Oct; 1046(3):233-41. PubMed ID: 2223863 [TBL] [Abstract][Full Text] [Related]
3. Content of dipalmitoyl phosphatidylcholine in lung surfactant: ramifications for surface activity. Holm BA; Wang Z; Egan EA; Notter RH Pediatr Res; 1996 May; 39(5):805-11. PubMed ID: 8726232 [TBL] [Abstract][Full Text] [Related]
4. In vivo function of surfactants containing phosphatidylcholine analogs. Dizon-Co L; Ikegami M; Ueda T; Jobe AH; Lin WH; Turcotte JG; Notter RH; Rider ED Am J Respir Crit Care Med; 1994 Oct; 150(4):918-23. PubMed ID: 7921463 [TBL] [Abstract][Full Text] [Related]
5. Importance of hydrophobic apoproteins as constituents of clinical exogenous surfactants. Hall SB; Venkitaraman AR; Whitsett JA; Holm BA; Notter RH Am Rev Respir Dis; 1992 Jan; 145(1):24-30. PubMed ID: 1731593 [TBL] [Abstract][Full Text] [Related]
6. An amphipathic alpha-helical decapeptide in phosphatidylcholine is an effective synthetic lung surfactant. McLean LR; Lewis JE; Krstenansky JL; Hagaman KA; Cope AS; Olsen KF; Matthews ER; Uhrhammer DC; Owen TJ; Payne MH Am Rev Respir Dis; 1993 Feb; 147(2):462-5. PubMed ID: 8430972 [TBL] [Abstract][Full Text] [Related]
7. Effects of surfactant subfractions on preterm rabbit lung function. Yamada T; Ikegami M; Jobe AH Pediatr Res; 1990 Jun; 27(6):592-8. PubMed ID: 2356104 [TBL] [Abstract][Full Text] [Related]
8. Cholesterol modifies the properties of surface films of dipalmitoylphosphatidylcholine plus pulmonary surfactant-associated protein B or C spread or adsorbed at the air-water interface. Taneva S; Keough KM Biochemistry; 1997 Jan; 36(4):912-22. PubMed ID: 9020791 [TBL] [Abstract][Full Text] [Related]
9. Activity and inhibition resistance of a phospholipase-resistant synthetic surfactant in rat lungs. Wang Z; Chang Y; Schwan AL; Notter RH Am J Respir Cell Mol Biol; 2007 Oct; 37(4):387-94. PubMed ID: 17556674 [TBL] [Abstract][Full Text] [Related]
10. [A coagulative type of pulmonary surfactant depletion--a mechanism of damage to the pulmonary surfactant system]. Koga Y Hokkaido Igaku Zasshi; 1994 May; 69(3):434-44. PubMed ID: 7927172 [TBL] [Abstract][Full Text] [Related]
13. Biophysical activity of an artificial surfactant containing an analogue of surfactant protein (SP)-C and native SP-B. Palmblad M; Johansson J; Robertson B; Curstedt T Biochem J; 1999 Apr; 339 ( Pt 2)(Pt 2):381-6. PubMed ID: 10191270 [TBL] [Abstract][Full Text] [Related]
14. Comparative studies on the biophysical activities of the low-molecular-weight hydrophobic proteins purified from bovine pulmonary surfactant. Yu SH; Possmayer F Biochim Biophys Acta; 1988 Aug; 961(3):337-50. PubMed ID: 3401500 [TBL] [Abstract][Full Text] [Related]
15. Protein- and lipid modification of natural bovine surfactant. Effects in experimental lung failure with special consideration of the response in neonates. Gortner L; Maroske W; Reiss I; Weller E Arzneimittelforschung; 2006; 56(1):25-32. PubMed ID: 16478002 [TBL] [Abstract][Full Text] [Related]
16. Effect of dexamethasone on pulmonary surfactant metabolism in hyperoxia-treated rat lungs. Ohashi T; Takada S; Motoike T; Tsuneishi S; Matsuo M; Sano K; Nakamura H Pediatr Res; 1991 Feb; 29(2):173-7. PubMed ID: 2014154 [TBL] [Abstract][Full Text] [Related]
17. Protein composition of synthetic surfactant affects gas exchange in surfactant-deficient rats. Walther FJ; Hernández-Juviel J; Bruni R; Waring AJ Pediatr Res; 1998 May; 43(5):666-73. PubMed ID: 9585014 [TBL] [Abstract][Full Text] [Related]
18. Inhibition of lung calcium-independent phospholipase A2 by surfactant protein A. Fisher AB; Dodia C; Chander A Am J Physiol; 1994 Sep; 267(3 Pt 1):L335-41. PubMed ID: 7943260 [TBL] [Abstract][Full Text] [Related]
19. Recovery of treatment doses of surfactants from the lungs and vascular compartments of mechanically ventilated premature rabbits. Seidner SR; Jobe AH; Ruffini L; Ikegami M; Pettenazzo A Pediatr Res; 1989 Apr; 25(4):423-8. PubMed ID: 2726320 [TBL] [Abstract][Full Text] [Related]
20. Lipid composition greatly affects the in vitro surface activity of lung surfactant protein mimics. Seurynck-Servoss SL; Brown NJ; Dohm MT; Wu CW; Barron AE Colloids Surf B Biointerfaces; 2007 May; 57(1):37-55. PubMed ID: 17287113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]